Cargando…
In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
Developing a safe and effective antiviral treatment takes a decade, however, when it comes to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the pandemic. Screening approved antiviral drugs against COVID-19 would speed the process of finding therapeutic treatmen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173495/ https://www.ncbi.nlm.nih.gov/pubmed/34099985 http://dx.doi.org/10.1016/j.bbrep.2021.101032 |